Literature DB >> 18330592

Visually-evoked P300 and NOGO potentials as indicators of central nervous system function in patients with vibration syndrome.

Mamoru Hirata1, Hisataka Sakakibara.   

Abstract

OBJECTIVE: The present study aimed at clarifying the effects of vibration syndrome (VS) on recognition, memory, and selective attention as well as suppression of hand movement in the central nervous system (CNS).
METHODS: Sixty-four patients with VS due to previous exposure to vibration from chain-saw work (Ch) or rock drilling work (RD) and 53 age-matched controls were examined for visually evoked P300 (V-P300) and NOGO potentials (NOGO-P). The patient group was divided into two subgroups, one with VS due to Ch work (Ch group, N = 17) and the other with VS due to RD work (RD group, N = 44).
RESULTS: ANOVA of latencies of V-P300 between three groups including two subgroups by vibration tools and controls was significant (P < 0.001), with significant difference between the control and RD subgroup (P < 0.001) and between the Ch and RD subgroups (P < 0.001). ANOVA of V-P300 amplitude was also significant (P < 0.001), with significant difference between the control group and RD subgroup (P = 0.042). NOGO-P was recorded in 28 of 37 controls (75.7%). Latencies of NOGO-P among VS patients were significantly delayed compared with those of controls (P = 0.0152). The proportions of subjects with abnormal values of V-P300 and NOGO-P among VS patients and RD operators were significantly higher than those in the control.
CONCLUSION: These findings suggest that VS affects CNS function as represented by V-P300 and NOGO-P.

Entities:  

Mesh:

Year:  2008        PMID: 18330592     DOI: 10.1007/s00420-008-0309-1

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


  25 in total

1.  The scalp topography of P300 in the visual and auditory modalities: a comparison of three normalization methods and the control of statistical type II error.

Authors:  E Naumann; C Huber; S Maier; W Plihal; A Wustmans; O Diedrich; D Bartussek
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1992-10

2.  Preclinical neurophysiological signs of parkinsonism in occupational manganese exposure.

Authors:  A Wennberg; M Hagman; L Johansson
Journal:  Neurotoxicology       Date:  1992       Impact factor: 4.294

3.  A study on the effect of lead on event-related potentials among lead-exposed workers.

Authors:  Mamoru Hirata; Hiroshi Kosaka; Toshiaki Yoshida
Journal:  Ind Health       Date:  2004-10       Impact factor: 2.179

4.  Manganese exposure in steel smelters a health hazard to the nervous system.

Authors:  A Wennberg; A Iregren; G Struwe; G Cizinsky; M Hagman; L Johansson
Journal:  Scand J Work Environ Health       Date:  1991-08       Impact factor: 5.024

5.  Transmission of hand-arm vibration to the head.

Authors:  H Sakakibara; T Kondo; M Miyao; S Yamada; T Nakagawa; F Kobayashi; Y Ono
Journal:  Scand J Work Environ Health       Date:  1986-08       Impact factor: 5.024

Review 6.  Determination of evoked potentials in occupational and environmental medicine: a review.

Authors:  S Araki; K Murata
Journal:  Environ Res       Date:  1993-10       Impact factor: 6.498

7.  Effects of night work on the cognitive function in young and elderly subjects with specific reference to the auditory P300.

Authors:  H Yasukouchi; S Wada; E Urasaki; A Yokota
Journal:  J UOEH       Date:  1995-12-01

8.  Neurological aspects of vibroacoustic disease.

Authors:  A J Martinho Pimenta; N A Castelo Branco
Journal:  Aviat Space Environ Med       Date:  1999-03

9.  Neurobehavioral effects of low-level methanol vapor exposure in healthy human volunteers.

Authors:  P Chuwers; J Osterloh; T Kelly; A D'Alessandro; P Quinlan; C Becker
Journal:  Environ Res       Date:  1995-11       Impact factor: 6.498

10.  Impaired manual dexterity and neuromuscular dysfunction in patients with hand-arm vibration syndrome.

Authors:  Hisataka Sakakibara; Mamoru Hirata; Norikuni Toibana
Journal:  Ind Health       Date:  2005-07       Impact factor: 2.179

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.